Prodex-Cardio - Cardiovascular autonomic control and hemodynamics: a comparison between long and short durations space missions.
From 01-01-2006 to 31-12-2008
Description
This project about human physiology/cardiology in space, deals with health related topics for astronauts as well as for earth applications. Basically we want to achieve: 1. Understanding the influence of 0g, reduced load on the body leading to systemic cardiovascular deconditioning. 2. Determine physiological adaptation mechanisms especially compare outcome of short stay in space versus long duration missions. Understanding mechanisms acting after long duration is important in relation to the time scale of long duration missions as are planned in the near future to the moon and to Mars. 3. Relate 0g physiological adaptation mechanisms to equivalent behaviour in daily life. In general the reduced load on the body in space will influence all functions, especially those related to our research: blood pressure and heart rate control and fluid balance. These phenomena are to some extend equivalent to syncope in patients on earth. To a lesser degree they are linked with the ageing process on earth 4. The input of an engineering related group will result in an interaction allowing to model cardiovascular control mechanisms taking all the specific space parameters into account. Moreover in the future, this can result in some diagnostic tools using noninvasive techniques and advanced sensors used in space, adapted for telemonitoring. 5. Finally it is hoped that after understanding and modelling of fundamental physiological behaviour under 0 g conditions, physiological countermeasures for astronauts will be developed. Earth equivalent can be leading to clinical countermeasures for better rehabilitation programs in patients.Team
- Sabine Van Huffel, Promoter
Financing
Funding: -
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.